1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Peripheral Vascular Stents Overview 13
3 Products under Development 14
3.1 Peripheral Vascular Stents – Pipeline Products by Stage of Development 14
3.2 Peripheral Vascular Stents – Pipeline Products by Segment 15
3.3 Peripheral Vascular Stents – Pipeline Products by Territory 16
3.4 Peripheral Vascular Stents – Pipeline Products by Regulatory Path 17
3.5 Peripheral Vascular Stents – Pipeline Products by Estimated Approval Date 18
3.6 Peripheral Vascular Stents – Ongoing Clinical Trials 19
4 Peripheral Vascular Stents – Pipeline Products under Development by Companies 20
4.1 Peripheral Vascular Stents Companies – Pipeline Products by Stage of Development 20
4.2 Peripheral Vascular Stents – Pipeline Products by Stage of Development 22
5 Peripheral Vascular Stents Companies and Product Overview 25
5.1 3D Biotek LLC Company Overview 25
5.2 480 Biomedical Inc Company Overview 26
5.3 Abbott Vascular Inc. Company Overview 30
5.4 Biotronik SE & Co KG Company Overview 32
5.5 Boston Scientific Corp Company Overview 37
5.6 C. R. Bard Inc Company Overview 43
5.7 Cardiatis SA Company Overview 45
5.8 Cook Medical Inc Company Overview 46
5.9 Cordis Corp Company Overview 58
5.10 Corinnova Inc Company Overview 62
5.11 Cytograft Tissue Engineering Inc Company Overview 63
5.12 Efferent Labs Inc Company Overview 64
5.13 Electroformed Stents Inc Company Overview 65
5.14 Elixir Medical Corp Company Overview 68
5.15 Hexacath Company Overview 70
5.16 InspireMD Inc Company Overview 72
5.17 Intact Vascular, LLC Company Overview 74
5.18 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 77
5.19 LimFlow GmbH Company Overview 79
5.20 Medinol Ltd Company Overview 81
5.21 Medtronic plc Company Overview 83
5.22 MicroVention, Inc. Company Overview 85
5.23 Natec Medical Ltd Company Overview 86
5.24 Nexeon MedSystems Inc Company Overview 87
5.25 Nipro Corp Company Overview 89
5.26 Northwestern University Company Overview 91
5.27 NSVascular, Inc. Company Overview 92
5.28 PeriTec Biosciences Ltd Company Overview 94
5.29 Stron Medical Company Overview 96
5.30 Synergy Flow Ltd Company Overview 98
5.31 Taewoong Medical Co.,Ltd. Company Overview 99
5.32 Tepha Inc Company Overview 109
5.33 TissueGen Inc Company Overview 110
5.34 University of Michigan Company Overview 112
5.35 University of Texas Medical Branch at Galveston Company Overview 113
5.36 Vascular Bioresorbable Technologies Company Overview 114
5.37 Vascular Concepts Ltd Company Overview 116
5.38 Veniti Inc Company Overview 119
5.39 Veryan Medical Limited Company Overview 122
5.40 VueKlar Cardiovascular Ltd Company Overview 126
5.41 Xenogenics Corporation Company Overview 129
6 Peripheral Vascular Stents- Recent Developments 132
6.1 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 132
6.2 Nov 21, 2016: VEITHsymposium 2016: BIOTRONIK Showcases Positive Results for Pulsar-18 Stent in the SFA 134
6.3 Nov 18, 2016: Abbott Labs Prices Public Offering of 4.75% Notes due 2036 for USD1.7 Billion 135
6.4 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 135
6.5 Nov 15, 2016: Final Patient Enrolled for Iliofemoral Venous Stent Study 136
6.6 Nov 15, 2016: LimFlow Receives CE Mark for Purely Percutaneous Critical Limb Ischemia Technology Designed to Restore Perfusion for “No Option” Patients 136
6.7 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 137
6.8 Nov 14, 2016: AngioDynamics Prices Public Offering of Shares for USD32 Million 138
6.9 Nov 14, 2016: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 138
6.10 Nov 14, 2016: Neovasc Reports Third Quarter Results for 2016 140
6.11 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 142
6.12 Oct 31, 2016: FDA Approves TOBA II BTK Pivotal IDE Clinical Study 143
6.13 Oct 27, 2016: CONMED Announces Third Quarter 2016 Financial Results 144
6.14 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 145
6.15 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 146
6.16 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 147
6.17 Oct 25, 2016: Bard Announces Third Quarter Results 149
6.18 Oct 24, 2016: Boston Scientific announced key Presentations on Eluvia Drug-Eluting Vascular Stent System at Transcatheter Cardiovascular Therapeutics 2016 149
6.19 Oct 20, 2016: Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA Bioresorbable Scaffold for Peripheral Vascular Disease 150
6.20 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 151
6.21 Oct 18, 2016: LimFlow Names Daniel Rose as Chief Executive Officer 153
6.22 Oct 11, 2016: Tepha Enters into Agreement with Metabolix 154
6.23 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 154
6.24 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 155
6.25 Sep 27, 2016: Boston Scientific Acquires EndoChoice for USD210 Million in Tender Offer 156
6.26 Sep 15, 2016: STENTYS Reports 2016 First-Half Results 156
6.27 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 157
6.28 Sep 08, 2016: VENITI Raises USD25 Million in Series D Equity Financing 158
6.29 Sep 07, 2016: GORE VIABAHN Endoprosthesis Marks 20 Years of Proven Performance 158
6.30 Sep 07, 2016: InspireMD Appoints Thomas Kester to Board of Directors 159
6.31 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 160
6.32 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 160
6.33 Aug 09, 2016: InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016 163
6.34 Aug 09, 2016: Neovasc Reports Second Quarter Results for 2016 165
6.35 Aug 03, 2016: EndoChoice Announces Second Quarter 2016 Financial Results 167
6.36 Aug 02, 2016: GORE TIGRIS Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease 169
6.37 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 170
6.38 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 171
6.39 Jul 27, 2016: CONMED Announces Second Quarter 2016 Financial Results 172
6.40 Jul 26, 2016: Merit Medical Announces Appointment of New Director 173
6.41 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 173
6.42 Jul 26, 2016: Bard Announces Second Quarter Results 175
6.43 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 176
6.44 Jul 21, 2016: Svelte Medical Systems Raises USD4 Million in Venture Financing 176
6.45 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results 176
6.46 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 178
6.47 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 179
6.48 Jul 12, 2016: STENTYS: 41% Increase in Revenues in the Second Quarter of 2016 180
6.49 Jul 05, 2016: Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements 180
6.50 Jul 04, 2016: STENTYS: Appointment of Cardiolovascular Device Veteran as New CEO 181
6.51 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 181
6.52 Jun 29, 2016: InspireMD Raises USD14.6 Million in Public Offering of Preferred Stock and Warrants 182
6.53 Jun 28, 2016: GORE VIABAHN Endoprosthesis Found to Provide Superior Patency and Reduced Interventions Versus Balloon Angioplasty Alone for Challenging AV Access Cases 182
6.54 Jun 20, 2016: VENITI Announces 1,000th Patient Treated With VICI VENOUS STENT 183
6.55 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 183
6.56 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 184
6.57 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 184
6.58 May 13, 2016: Boston Scientific Announces Presentation of Eluvia stent system at EuroPCR 2016 187
6.59 May 10, 2016: InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016 187
6.60 May 04, 2016: Positive Twelve-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at SCAI 2016 189
6.61 May 02, 2016: A.G. Schneiderman Announces $306 Million National Settlement With Olympus 190
6.62 Apr 29, 2016: Neovasc Reports First Quarter Results for 2016 190
6.63 Apr 21, 2016: VENITI Completes First Use Of VICI VERTO VENOUS STENT, Novel Venous Stent System 193
6.64 Apr 20, 2016: Abbott Reports First-Quarter 2016 Results 193
6.65 Apr 13, 2016: STENTYS Reports 38% Increase in Revenues in First Quarter 2016 196
6.66 Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results 196
6.67 Apr 04, 2016: AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer 197
6.68 Mar 29, 2016: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2015 198
6.69 Mar 16, 2016: STENTYS Reports 2015 Annual Results 201
6.70 Mar 15, 2016: InspireMD Raises USD0.6 Million in Private Placement of Shares and Warrants 202
6.71 Mar 04, 2016: Palmaz Scientific Announces Chapter 11 Filing; Seeks Prospective Buyers for Its Breakthrough Technology 202
6.72 Feb 22, 2016: Boston Scientific Receives CE Mark For Eluvia Drug-Eluting Vascular Stent And Announces Initiation Of New Clinical Trial 203
6.73 Feb 12, 2016: Stentys Raises USD14.3 Million in Rights Offering of Shares 204
6.74 Feb 08, 2016: STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication 205
6.75 Jan 26, 2016: Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016 205
6.76 Jan 13, 2016: STENTYS Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues 206
6.77 Jan 07, 2016: AngioDynamics Reports Fiscal 2016 Second Quarter Results 207
7 Appendix 209
7.1 Methodology 209
7.2 About GlobalData 212
7.3 Contact Us 212
7.4 Disclaimer 212